Machine learning and radiomics for predicting efficacy of programmed cell death protein 1 inhibitor for small cell lung cancer: A multicenter cohort study.

Journal: Clinical and translational medicine
PMID:

Abstract

No abstract available for this article.

Authors

  • Pulin Li
    Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Ling Huang
    School of Civil Engineering and Transportation, South China University of Technology, Guangzhou, 510640, China.
  • Rui Han
    China Environment Publishing Group, Beijing, 100062, People's Republic of China.
  • Min Tang
    Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
  • Guanghe Fei
    Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Daxiong Zeng
    Department of Pulmonary and Critical Care Medicine, Medical Center of Soochow University, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, China.
  • Ran Wang
    Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.